The Trump administration is in negotiations to obtain popular weight-loss drug Ozempic at a dramatically reduced price in the United States, according to President Donald Trump.
The drug, made by Danish manufacturer Novo Nordisk, will be sold at most-favored nation pricing, meaning the lowest price available in developed countries.
“In London, you’d buy a certain drug for $130 and even less than that … And in New York, you pay $1,300 for the same thing,” Trump said in the White House announcement.
“Now you’ll be paying … about $150 and they’ll be paying $150, so we’ll pay the same thing,” Trump said.
In a later question-and-answer exchange with reporters, Trump confirmed that he had been referring to Ozempic....